Curated News
By: NewsRamp Editorial Staff
August 18, 2026
SS Innovations Q2 Revenue Soars 39% on SSi Mantra Demand
TLDR
- SS Innovations' record Q2 revenue of $13.9M, up 39.4%, signals strong growth and potential for market share gains.
- SS Innovations' Q2 2026 revenue grew 39.4% to $13.9M, with installations up 30.4% and telesurgery expanding clinical reach.
- SS Innovations' telesurgery and growing installed base of 224 systems improve access to robotic surgery across 12 countries.
- SS Innovations' SSi Mantra has performed 12,272 surgeries, with FDA clearance targeted by Q1 2027 and CE mark by end of 2026.
Impact - Why it Matters
This news matters because it highlights the rapid growth and market acceptance of SS Innovations' SSi Mantra surgical robotic system, which is poised to compete with established players in the surgical robotics industry. The company's financial performance and upcoming regulatory milestones indicate potential for broader adoption and market expansion, which could impact healthcare providers, investors, and patients by offering a more accessible and innovative robotic surgery option.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, announced record second-quarter revenue of $13.9 million, a 39.4% increase year over year, driven by strong demand for its SSi Mantra surgical robotic system. The company's first-half revenue reached $25.0 million, up 65.6% from the prior year, with gross profit rising 77.5% to $12.4 million. SSi Mantra installations grew 30.4% to 30 systems during the quarter, bringing the total installed base to 224 systems across 12 countries, with 12,272 cumulative surgeries performed to date.
The company is making significant progress in regulatory milestones, targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026, which could serve as major catalysts. Additionally, SS Innovations' telesurgery achievements are expanding the clinical profile of SSi Mantra, while system installations remain the primary commercial growth driver. The company's robust performance underscores its position in the surgical robotics market, with a focus on expanding its global footprint and advancing its technology platform.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Q2 Revenue Soars 39% on SSi Mantra Demand
